Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Biofilms are microbial communities, embedded in a polymeric matrix, growing attached to a surface. Nearly all device-associated infections involve growth in the biofilm life style. Biofilm communities have characteristic architecture and distinct phenotypic properties. The most clinically important phenotype involves extraordinary resistance to antimicrobial therapy, making biofilm infections very difficulty to cure without device removal. The current studies examine drug resistance in Candida albicans biofilms. Similar to previous reports, we observed marked fluconazole and amphotericin B resistance in a C. albicans biofilm both in vitro and in vivo. We identified biofilm-associated cell wall architectural changes and increased β-1,3 glucan content in C. albicans cell walls from a biofilm compared to planktonic organisms. Elevated β-1,3 glucan levels were also found in the surrounding biofilm milieu and as part of the matrix both from in vitro and in vivo biofilm models. We thus investigated the possible contribution of β-glucans to antimicrobial resistance in Candida albicans biofilms. Initial studies examined the ability of cell wall and cell supernatant from biofilm and planktonic C. albicans to bind fluconazole. The cell walls from both environmental conditions bound fluconazole; however, four- to fivefold more compound was bound to the biofilm cell walls. Culture supernatant from the biofilm, but not planktonic cells, bound a measurable amount of this antifungal agent. We next investigated the effect of enzymatic modification of β-1,3 glucans on biofilm cell viability and the susceptibility of biofilm cells to fluconazole and amphotericin B. We observed a dose-dependent killing of in vitro biofilm cells in the presence of three different β-glucanase preparations. These same concentrations had no impact on planktonic cell viability. β-1,3 Glucanase markedly enhanced the activity of both fluconazole and amphotericin B. These observations were corroborated with an in vivo biofilm model. Exogenous biofilm matrix and commercial β-1,3 glucan reduced the activity of fluconazole against planktonic C. albicans in vitro. In sum, the current investigation identified glucan changes associated with C. albicans biofilm cells, demonstrated preferential binding of these biofilm cell components to antifungals, and showed a positive impact of the modification of biofilm β-1,3 glucans on drug susceptibility. These results provide indirect evidence suggesting a role for glucans in biofilm resistance and present a strong rationale for further molecular dissection of this resistance mechanism to identify new drug targets to treat biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, although β-1,3-glucans contribute to drug resistance and are the major cell wall polysaccharide (130), we now know that they constitute only a small fraction of the total polysaccharides present, implying that the matrix is not constructed simply of released cell wall constituents.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One known constituent of the biofilm matrix that contributes to its drug-resistance properties is the polysaccharide β-1,3-glucan (130).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Few studies have shown that fluconazole-resistant (FR) C. albicans may also exhibit higher levels of β-glucans compared to susceptible strains (12, 16).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher levels of β-glucans absorb fluconazole and inhibit its penetration to the site of action (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-glucans can act as a physical barrier, reducing the accessibility of fluconazole to its target sites in the cell membrane and limiting its effectiveness (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269 · cited 1×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described (18, 22 , 40).”
MethodBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17 , 20, 21, 24, 41, 46, 50).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20 , 21, 24, 41, 46, 50).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921 · cited 2×
“Previous studies in a bacterial biofilm model demonstrated sequestration of antimicrobial compounds by a cell wall component, specifically, the -1,3 glucan component of biofilm cells (33, 34 ).”
BackgroundMethods in yeast genetics : a Cold Spring Harbor Laboratory course manual
Amberg, D. C., Burke, D. J., & Strathern, J. N. (2005) · Cited by 1,803
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 3×
“C. albicans is a major human pathogen which can grow as a biofilm and inhabit the surface of many medical devices (28, 44 ).”
BackgroundInfluentialClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“A number of molecular mechanisms have been implicated in nonbiofilm antifungal resistance in C. albicans ( 54 ).”
BackgroundA genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans ( 21 , 28, 45, 46).”
Background
Research works printed but not linked: 1
- 19. Dijkgaraff, G. J. P., J. L. Brown, and H. Bussey. 1996. The KHN1 gene of Saccharomyces cerevisiae is a functional homolog of KRE9 . Yeast. 12: 683692. · DOI · Paper page
Cited by
Items 301–400 of 414
Kumar, A., Francis, A., Hans, S., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_8 · Cited by 7
Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
LaFleur, M. D. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010021 · Cited by 9
“In addition, biofilm spent medium, but not supernatant derived from planktonic culture, was reported to bind fluconazole [75].”
BackgroundYeast Biofilms in the Context of Human Health and Disease
Raut, J. S., Doke, S. K., & Karuppayil, S. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-2621-8_6 · Cited by 6
Montejo, M., & Quindós, G. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70004-0 · Cited by 8
Medically Important Interactions of Staphylococci with Pathogenic Fungi
Kumari, A., & Singh, R. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0155 · Cited by 7
Candida albicans Mrv8, is involved in epithelial damage and biofilm formation
Costa, A. C. B. P., Back‐Brito, G. N., Mayer, F. L., Hube, B., & Wilson, D. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa033 · Cited by 6
“…by the molecular chaperone Hsp90 through regulation of the calcineurin pathway and its downstream transcription factor, Crz1 (Chandra et al. 2001; Nett et al. 2007; Singh et al. 2009; Nett et al. 2011; Robbins et al. 2011; Ramage et al. 2012; Taff et al. 2012; Tobudic et al. 2012; Mathe and…”
BackgroundFungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch2 · Cited by 8
Self-citationThe Role of Resistance in Candida Infections: Epidemiology and Treatment
Sobel, J. D., & Akins, R. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_18 · Cited by 7
Botelho, T. K. R., Danielli, L. J., Seide, M., Borges, P. P., & Cruz, A. B. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e20727 · Cited by 6
Mucosal Immunity to Candida albicans
Fidel, P. L., & Noverr, M. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch10 · Cited by 6
Pathogen Evasion of Humoral Innate Immunity: Coping with C-Reactive Protein and Serum Amyloid A
Gong, W., Cheng, X., Villena, J., & Kitazawa, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021072 · Cited by 5
Liu, C., & Shao, J. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106139 · Cited by 6
Antimicrobial Tolerance in Cross-Kingdom Dual-Species Biofilms Formed by Fungi and Bacteria
Kurakado, S., Matsumoto, Y., Eshima, S., & Sugita, T. (2024) · Medical Mycology Journal · doi:10.3314/mmj.24.004 · Cited by 7
Electrically Conductive Catheter Inhibits Bacterial Colonization
Amalou, H., Negussie, A. H., Ranjan, A., Chow, L., Xu, S., Kroeger, C., Neeman, Z., O’Grady, N. P., & Wood, B. J. (2014) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2014.01.032 · Cited by 5
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 7
Růžička, F., Horká, M., & Holá, V. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-875-1_5 · Cited by 5
Candidiasis and Less Common Yeast Genera
Reiss, E., Shadomy, H. J., & Lyon, G. M. (2011) · Wiley eBooks · doi:10.1002/9781118101773.ch11 · Cited by 6
Snarr, B. D., Howell, P. L., & Sheppard, D. C. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0243 · Cited by 5
Ziental, D., Giuntini, F., Wysocki, M., Talarska, P., Kubicka, A., Długaszewska, J., & Sobotta, Ł. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146949 · Cited by 4
“A characteristic feature of C. albicans biofilm formation is the presence of α -mannan, β -1,6-glucan, and β -1,3-glucan [28].”
Current and emerging therapies for fungal biofilms and systemic infections
Elgammal, Y., Martinez, R. I. G., Requejo, A., & Martinez, L. R. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2570185 · Cited by 4
Zhao, Y., Zou, W., Su, C., & Lu, Y. (2026) · iFungi · doi:10.26599/ifungi.2026.9670011 · Cited by 4
Villanueva-Cotrina, F., Béjar, V., Guevara, J., Cajamarca, I., Medina, C., Mujica, L., & Lescano, A. G. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10044-5 · Cited by 4
Dias, L. M., Marin, L. M., Pavarina, A. C., & Siqueira, W. L. (2025) · ACS Omega · doi:10.1021/acsomega.5c02108 · Cited by 4
In Vivo Candida Device Biofilm Models
Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_7 · Cited by 5
Self-citationAbreu‐Pereira, C. A., Pereira, A. L. G., Jordão, C. C., Paro, C. B., Barbugli, P. A., & Pavarina, A. C. (2025) · Journal of Dentistry · doi:10.1016/j.jdent.2025.105631 · Cited by 4
Biofilm Formation in Candida albicans
Finkel, J. S., & Mitchell, A. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch19 · Cited by 5
ElGindi, M., Al-Baghdadi, R., Jackman, A. B., Antonyan, A. S., McMahon, D. L., Taj‐Aldeen, S. J., & Finkel, J. S. (2021) · Canadian Journal of Microbiology · doi:10.1139/cjm-2020-0215 · Cited by 4
Novel Materials for Eradication of Biofilm Extracell Matrix of Pathogenic Candida
Afaf, Baktir, Hery, H., Suwito, S., Merry, M., Safinah, Baterun, & Kunsah (2012) · Journal of Materials Science and Engineering B · Cited by 4
Host-Fungal Interactions: Pathogenicity versus Immunity
Tavanti, A., Naglik, J. R., & Osherov, N. (2012) · International Journal of Microbiology · doi:10.1155/2012/562480 · Cited by 5
Cho, T., Nagao, J.-I., Imayoshi, R., Kodama, J., Morotomi, T., & Kaminishi, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00228 · Cited by 4
Biofilm formation in Zymoseptoria triticiPreprint
Tyzack, T. E., Hacker, C., Thomas, G., & Fones, H. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.26.550639 · Cited by 10
“Studies have provided evidence for hypotheses including sequestration of antimicrobials by ECM components[24, 25], higher expression of efflux pumps in biofilm compared to pelagic cells[15, 26] and the effect of lowered metabolic rates inside biofilms on antimicrobial metabolism and efficacy[27, 28].”
BackgroundMeng, X., Zhao, Y., Xiang, Q., Wu, J., Gong, X., Wang, Y., Chen, L., & Zhang, P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166603 · Cited by 3
Calvi, G. D. S., Braga, M. T., Cartaxo, G. N. J., Kubát, P., Liška, V., Mosinger, J., & Costa, M. S. (2026) · ACS Omega · doi:10.1021/acsomega.5c08078 · Cited by 3
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 4
Introduction to Fundamental Medical Mycology
Reiss, E., Shadomy, H. J., & Lyon, G. M. (2011) · Wiley eBooks · doi:10.1002/9781118101773.ch1 · Cited by 4
Inhibition and Removal of Mature Mixed-Bacteria Biofilms on Voice Prostheses by Sodium Selenite
Zhang, Y., Niu, Y., Huo, H., Wang, J., Jin, X., & Yang, H. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s393434 · Cited by 3
Radchenkova, N., Stefanova, P. P., & Gouliamova, D. E. (2025) · Life · doi:10.3390/life15060889 · Cited by 3
Preventing Candida albicans biofilm formation using aromatic-rich piperazines
Simon, G., Bérubé, C., Paquet-Côté, P.-A., Grenier, D., & Voyer, N. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115810 · Cited by 3
Contributions of Extracellular Vesicles to Fungal Biofilm Pathogenesis
Heredia, M. Y., & Andes, D. R. (2021) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-83391-6_7 · Cited by 3
Self-citationMasfufatun, M., Purbowati, R., Arum, N. A., Yasinta, M. S., Sumarsih, S., & Baktir, A. (2022) · Veterinary World · doi:10.14202/vetworld.2022.1134-1140 · Cited by 7
Huang, M., Yang, L., Zhou, L., Sun, C., Zhao, W., Peng, J., Jiao, Z., Tian, C., & Guo, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.990318 · Cited by 3
“The matrix acts as both a physical barrier to drug penetration and as a stabilizer of the overall architecture of the biofilms (Nett et al., 2007; Nobile and Johnson, 2015), isolating antifungal molecules and preventing them from penetrating deeper into the biofilm (Pierce et al.”
BackgroundAntibiofilm Effect of Siegesbeckia pubescens against S. mutans According to Environmental Factors
Zheng, S., Bellere, A. D., Oh, S., Yu, D., Fang, M., & Yi, T. (2023) · Applied Sciences · doi:10.3390/app13106179 · Cited by 4
Cagnacci, S., Grasso, R., Marchese, A. E., Corvò, R., Debbia, E. A., & Rossi, L. A. (2008) · The Open Microbiology Journal · doi:10.2174/1874285800802010066 · Cited by 3
“Consistent with this view are a number of reports, including the observation that yeast and hyphal forms have different levels of DNA methylation [21], and the more recent identification of an increased content in -1,3 glucan in the cell wall of sessile compared to planktonic Candida [22].”
ResultPreparation of Candida albicans Biofilms for Transmission Electron Microscopy
Taff, H. T., & Andes, D. R. (2013) · BIO-PROTOCOL · doi:10.21769/bioprotoc.822 · Cited by 3
Self-citationClinical Implications of Candida Biofilms
Bernardo, S. M., Ilieva, V. P., Walraven, C. J., & Lee, S. A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0302-9 · Cited by 3
Masfufatun, M., Raharjo, L. H., Wiradinata, H., Tania, P. O. A., Ni’matuzahroh, N., & Baktir, A. (2021) · International Journal of One Health · doi:10.14202/ijoh.2021.165-170 · Cited by 4
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_20 · Cited by 4
Self-citationUrinary Tract Infections: Fungi (Candida spp.)
Silao, F. G. S., Álvarez, F. J., Taladtad, F. F., Viloria, T. A. M. D., & Ljungdahl, P. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00140-3 · Cited by 3
Schöpf, C., Geschwindt, A., Knapp, M., Seybold, A., Coraça-Huber, D. C., Ausserlechner, M. J., Romanelli, A., & Marx, F. (2025) · Journal of Fungi · doi:10.3390/jof12010011 · Cited by 2
Das, S., Baradarbarjastehbaf, F., Szokolics, A. S., Campos, G. K. D., Gazdag, Z., Széchenyi, A., Miseta, A., Kovács, G. L., & Kőszegi, T. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040508 · Cited by 2
The Role of Resistance in Candida Infections: Epidemiology and Treatment
Sobel, J. D., & Akins, R. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_18 · Cited by 4
Cho, E., Choi, J. M., & Jung, S. (2011) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2011.32.1.347 · Cited by 2
Les échinocandines : mise au point
Pilmis, B., Lopes, A., Lortholary, O., & Charlier, C. (2013) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.02.005 · Cited by 2
Djimeli, C. L., Arfao, A. T., Ewoti, O. V. N., Bricheux, G., Nola, M., & Sime‐Ngando, T. (2014) · HAL · Cited by 3
Candida Albicans Biofilm as a Clinical Challenge
Jadhav, A. K., & Karuppayil, S. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-4768-8_13 · Cited by 3
Emergence of Multidrug Resistance Microbes: Bacteria, Fungi, and Viruses
Malhotra, N., Kumar, P., Ramakrishnan, S., & Rohaun, S. K. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080056123020005 · Cited by 2
The Impact of Antifungal Drug Resistance in the Clinic
Lewis, R. E., & Kontoyiannis, D. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch23 · Cited by 2
Clinical Significance, Molecular Formation, and Natural Antibiofilm Agents of Candida albicans
Abdulghani, M. M. M., & Zore, G. B. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_9 · Cited by 2
Badawy, S., Sandrasagra, J., Byles-Ho, C., & Salathiel, T. (2024) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.673 · Cited by 1
The antibiofilm potential of Clidemia hirta against Candida albicans: preliminary study
Desrini, S. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07209-z · Cited by 1
“Thus, the drug fails to kill the yeast cells [6].”
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
da Silva, M. E. B., Kamio, A. B. S., da Silva, M. G. R., dos Santos, H. S., Mazzon, R. R., Cuevas‐Suárez, C. E., Lund, R. G., Ribeiro, J. S., & Badaró, M. M. (2026) · Journal of Prosthetic Dentistry · doi:10.1016/j.prosdent.2026.02.023 · Cited by 1
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_13 · Cited by 1
Candidiasis and the impact of flow cytometry on antifungal drug discovery
Ku, T. S. N., Bernardo, S. M., Walraven, C. J., & Lee, S. A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1377179 · Cited by 1
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_20-1 · Cited by 2
“The Andes group added isolated Candida biofilm matrix to planktonic MIC assays and found that this material was able to provide a degree of antifungal resistance to the non-biofilm cells (Nett et al. 2007).”
ResultInfluentialSelf-citationEvolution of Drug Resistance in Fungi
Hill, J. A., Hoot, S. J., White, T. C., & Cowen, L. E. (2012) · Wiley eBooks · doi:10.1002/9781118308165.ch8 · Cited by 1
Luthfi, M., Kriswandini, I. L., & Zaba, F. H. (2017) · Dental Journal (Majalah Kedokteran Gigi) · doi:10.20473/j.djmkg.v49.i2.p71-75 · Cited by 1
Seneviratne, C. J., Truong, T., & Wang, Y. (2017) · CRC Press eBooks · doi:10.4324/9781315120119-5 · Cited by 1
ANTIFUNGAL AGENTS IN TERMS OF ACQUIRED RESISTANCE IN CANDIDA SPECIES
Iungin, O. S. (2018) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2018-2-144-83-86 · Cited by 3
Role of Glucan-Derived Polymers in the Pathogenic Fungus Candida albicans
Prieto, D., Román, E., Alonso‐Monge, R., & Plá, J. (2019) · Biologically-inspired systems · doi:10.1007/978-3-030-12919-4_9 · Cited by 1
Ramage, G., Mowat, E., Williams, C., & Lopez-Ribot, J. L. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_6 · Cited by 3
Mahalingam, S. R. R., Madhavan, P., & Chong, P. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.30.016246 · Cited by 1
Host-Induced Stress Response in Human Pathogenic Fungi
Viana, R., Pais, P., Cavalheiro, M., Galocha, M., & Teixeira, M. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819990-9.00035-4 · Cited by 1
Candida albicans Colonization and Community Development
Jenkinson, H. F., & Munro, C. A. (2011) · Wiley eBooks · doi:10.1128/9781555817107.ch12
Overcoming the antifungal drug resistance of biofilms on dental acrylic
Newsham-West, K. (2013) · Otago University Research Archive (University of Otago) · Cited by 1
CANDIDA YEASTS AND CARCINOGENIC ACETALDEHYDE IN UPPER DIGESTIVE TRACT CARCINOGENESIS
Nieminen, M. T. (2014) · Helda - University of Helsinki Institutional Repository
Characterization and eradication of persisters in Candida albicans biofilms
Fleur, L., & David, M. Z. (2008)
Investigation of antifungal resistance exhibited by candida albicans
Attavar, S. (2012) · J. Willard Marriott Library · doi:10.26053/0h-82b3-wc00
Wille, M. P. (2010) · Americanae (AECID Library)
Immunomodulation of myeloid-derived suppressor cells by particulate b-glucan in cancer.
Albeituni, S. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2332
Rat Indwelling Urinary Catheter Model of Candida albicans
Nett, J. E., Brooks, E. G., Cabezas‐Olcoz, J., Sánchez, H., Żarnowski, R., Marchillo, K., & Andes, D. R. (2014)
Self-citationde Souza, L. B. F. C. (2015) · Americanae (AECID Library)
Hydrodynamic effects on development of mat-like biofilm in a microfluidic environment
Kim, J.-H., Han, S., Chung, S. H., & Park, H. D. (2012) · International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS)
Hill, J. A. (2014) · TSpace (University of Toronto)
Richter, C., Schneider, S., Rapp, B. E., Schmidt, S., Schüßler, M., Jakoby, R., Bruchmann, J., Bischer, M., & Schwartz, T. (2018) · Frequenz · doi:10.1515/freq-2018-0005
Lee, K. K., & Munro, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-55013-3_7
Celis, D. A. L., Aponte, J. A. M., & Castillo, J. M. M. (2019) · Cited by 1
(2007) · Yeast · doi:10.1002/yea.1453
Candida Biofilms: Properties, Antifungal Resistance and Novel Therapeutic Options
Seneviratne, C. J., Truong, T., & Wang, Y. (2017) · Routledge eBooks · doi:10.1201/9781315120119-6 · Cited by 1
Vila, T. V. M., Montelongo‐Jauregui, D., Romo, J. A., Wall, G., Pierce, C. G., & Lopez-Ribot, J. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.12092-8
Ottah, V., Ezugwu, A. L., Ezike, T. C., & Chilaka, F. C. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4095851
Candida: Biofilm formation and antifungal resistance
Sharma, S., Singh, S. M., Mane, G., Pote, S. T., Patole, M. S., & Sharma, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99977-9.00024-7
Martins, B. L., Bovi, L. D. A., Rustiguel, C. B., Neves, F. T. A., Politi, F. A. S., & de Queiroz, G. M. (2023) · Revista Ciência Tecnologia & Ambiente · doi:10.4322/2359-6643.13241
Vigué, A. (2021) · theses.fr (ABES) · doi:10.70675/596a1648z9eeaz4782z8516z8536ab4c67d8 · Cited by 1
Management of Denture Stomatitis with a Herbal Armamentarium
Chauhan, V., Saxena, P., Nautiyal, A., & Gupta, P. (2024) · Current Dentistry · doi:10.2174/012542579x317149241202064449 · Cited by 1
The Extracellular Matrix: A Scaffold for Microbial Community Assembly and Function
Kim, D., & Klein, M. I. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-82202-5_5 · Cited by 1
Composition and Role of the Extracellular Matrix in Fungal Biofilm Drug Resistance
Kim, M.-J., Żarnowski, R., & Andes, D. R. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_8 · Cited by 1
Self-citationBalasubramanian, H. K., & Osmani, S. A. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2547194 · Cited by 1
“Biofilms are characterized by the presence of an extracellular matrix comprising proteins, polysaccharides, lipids, and nucleic acids [1–3] .”
Pancatalytic biomaterials enable inflammation-related disease intervention
Jiang, X., & Chen, Y. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00408j
Metadata
- Authors
- Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D.
- Affiliations
- University of Wisconsin–Madison (US)
- Departments of Medicine and Medical Microbiology and Immunology
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 51
- Issue
- 2
- Pages
- 510-520
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1797745
- OpenAlex
- W1999751604
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 22 · 2022: 20 · 2021: 15 · 2020: 26 · 2019: 19 · 2018: 22 · 2017: 34 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 20 · 2012: 23
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, β-1,3-glucan, antifungal resistance, fluconazole resistance, amphotericin B resistance, β-glucanase, cell wall architecture, biofilm matrix, planktonic versus biofilm cells, device-related infection, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Candida albicans, Microbial Sensitivity Tests, Fluconazole, Biofilms, Drug Resistance, Fungal, Glucan 1,3-beta-Glucosidase, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.